Form D · Pharmaceuticals
INFACARE PHARMACEUTICAL CORP
Trevose, PA · CIK 0001174264
Offering snapshot reported Jun 7, 2017 · SEC filing
- Reported sold
- $3.5M Offering amount: $11M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 24, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 7, 2017 | Initial | $3,500,000 | No comparison | 11 | SEC filing |
| Nov 4, 2016 | Initial | $5,500,000 | No comparison | 11 | SEC filing |
| Jul 8, 2015 | Initial | $12,100,000 | No comparison | 10 | SEC filing |
| Dec 9, 2014 | Initial | $1,300,000 | No comparison | 2 | SEC filing |
| Oct 21, 2014 | Initial | $750,000 | No comparison | 6 | SEC filing |
| Mar 20, 2013 | Initial | $3,556,876 | No comparison | 6 | SEC filing |
| Oct 23, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 23, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-288227
Promissory Note convertible into equity of the Company.
Source: Form D, filed Jun 7, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Barrett | Director |
| Dan Burns | Director, Executive |
| William Crouse | Director |
| Patrick Enright | Director |
| Ron Goldfuss | Executive |
| E. Ronald Goldfuss | Executive |
| Richard Vietor | Director |
| Robert Vukovich | Director |
| Harold Werner | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8 Neshaminy Interplex, Suite 221
Trevose, PA, 19053
Trevose, PA, 19053